Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Mar. 2026, Abacus Global Management has a Sloan Ratio of -8.19%, indicating the company is in the safe zone and there is no funny business with accruals.
Abacus Global Management (NYSE:ABX) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Abacus Global Management has a Sloan Ratio of -8.19%, indicating the company is in the safe zone and there is no funny business with accruals.
Abacus Global Management Sloan Ratio % Related Terms
Abacus Global Management Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Life subindustry, Abacus Global Management's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abacus Global Management Sloan Ratio % vs Insurance Industry
For the Insurance industry and Financial Services sector, Abacus Global Management's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Abacus Global Management's Sloan Ratio % falls into.
Abacus Global Management Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Abacus Global Management's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
Abacus Global Management's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 17.584 (Jun. 2025 ) + 7.075 (Sep. 2025 ) + 7.227 (Dec. 2025 ) + 7.266 (Mar. 2026 ) = $39.2 Mil.
Abacus Global Management's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 76.102 (Jun. 2025 ) + -32.752 (Sep. 2025 ) + -7.44 (Dec. 2025 ) + 91.686 (Mar. 2026 ) = $127.6 Mil.
Abacus Global Management's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was -10.004 (Jun. 2025 ) + -0.236 (Sep. 2025 ) + -9.3 (Dec. 2025 ) + -0.932 (Mar. 2026 ) = $-20.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abacus Global Management (ABX) has a Sloan Ratio % of -8.19% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Abacus Global Management and its competitors.
Is Abacus Global Management's Sloan Ratio % too high?
Abacus Global Management's current Sloan Ratio % is -8.19%. Overall, Abacus Global Management has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abacus Global Management's Sloan Ratio % compare to KCLI and SNFCA?
Abacus Global Management's Sloan Ratio % of -8.19% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for an Insurance company?
A good Sloan Ratio % depends on the Insurance industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Abacus Global Management and its competitors. Abacus Global Management's current Sloan Ratio % is -8.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abacus Global Management stock overvalued right now?
Based on GuruFocus' analysis, Abacus Global Management (ABX) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.55, compared to a current price of $10.31 — trading 23.9% below its estimated fair value. The current Sloan Ratio % is -8.19%. Abacus Global Management's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Abacus Global Management (ABX), the current Sloan Ratio % is -8.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abacus Global Management (ABX) Overvalued in 2026?
Based on GuruFocus' analysis, Abacus Global Management stock appears to be undervalued.
The current stock price of $10.31 is trading 23.9% below its estimated GF Value™ of $13.55.
GuruFocus considers Abacus Global Management to be Modestly Undervalued.
Key valuation signals for ABX:
Sloan Ratio %: -8.19%
GF Value™: $13.55 vs. price of $10.31 (23.9% below fair value)
No single metric tells the full story. See the ABX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The company operates through four distinct yet complementary divisions: Abacus Life Solutions, Abacus Asset Group, Abacus Intel, and Abacus Wealth Advisors. It operates through three reportable segments, Asset management, Life solutions, and Technology services. It derives the majority revenue from Life solutions segment that generates revenues by buying, selling, and trading policies, and maintaining policies until receipt of death benefits. It also generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner.
63GF Score
Get the complete analysis for ABX
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABX has been successfully added to your 
